Faes Farma (ES:FAE) has released an update.
Faes Farma’s General Shareholders’ Meeting has approved all board proposals, including the appointment of Eduardo Recoder de la Cuadra as executive director and the director remuneration policy for 2025-2027. Shareholders were informed of a 10% decrease in share value in 2023 but were also promised cash dividends totaling 0.155 euros per share. The company celebrated historical results in 2023 with a consolidated profit of 91.7 million euros and forecasts continued revenue and EBITDA growth for 2024.
For further insights into ES:FAE stock, check out TipRanks’ Stock Analysis page.
